Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg
NCT00648336
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Mercaptopurine 50 mg
DRUG:
Purinethol® Tablets 50 mg
Sponsor
Mylan Pharmaceuticals Inc